Bioethics (BOTH) Stock Statistics & Valuation Metrics
Total Valuation
Bioethics has a market cap or net worth of $18.36K. The enterprise value is $589.38B.
- Market Cap
- $18.36K
- Enterprise Value
- $589.38B
Share Statistics
Bioethics has 3,600,194 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,600,194
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Bioethics’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 35.54%.
- Return on Equity (ROE)
- 0.19
- Return on Assets (ROA)
- -12.07
- Return on Invested Capital (ROIC)
- 35.54%
- Return on Capital Employed (ROCE)
- 0.13
- Revenue Per Employee
- 0
- Profits Per Employee
- -176.96K
- Employee Count
- 1
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Bioethics is -0.04. Bioethics’s PEG ratio is 0.00.
- PE Ratio
- -0.04
- PS Ratio
- 0.00
- PB Ratio
- -0.01
- Price to FCF
- -0.12
- Price to Operating Cash Flow
- -0.05
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Bioethics had revenue of 0 and earned -176.96K in profits. Earnings per share was -0.12.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -122.82K
- Pretax Income
- -176.96K
- Net Income
- -176.96K
- EBITDA
- 0
- Earnings Per Share (EPS)
- -0.12
Cash Flow
In the last 12 months, operating cash flow was -150.43K and capital expenditures 0, giving a free cash flow of -150.43K billion.
- Operating Cash Flow
- -150.43K
- Free Cash Flow
- -150.43K
- Free Cash Flow per Share
- -0.10
Dividends & Yields
Bioethics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -819.29%
- Earnings Yield
- -2323.80%
Stock Price Statistics
- Beta
- -0.72
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 1.25
- 200-Day Moving Average
- 1.25
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Bioethics as a current ratio of 0.02, with Debt / Equity ratio of -62.89%
- Current Ratio
- 0.02
- Quick Ratio
- 0.02
- Debt to Market Cap
- 0.34
- Net Debt to EBITDA
- -4.65
- Interest Coverage Ratio
- -2.27
Taxes
In the past 12 months, Bioethics has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Bioethics EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -3.92.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.00
- EV to Free Cash Flow
- -3.92
- EV to Operating Cash Flow
- -3.92
Balance Sheet
Bioethics has $14.66K in cash and marketable securities with $585.69K in debt, giving a net cash position of -$571.02K billion.
- Cash & Marketable Securities
- $14.66K
- Total Debt
- $585.69K
- Net Cash
- -$571.02K
- Net Cash Per Share
- -$0.16
- Tangible Book Value Per Share
- -$0.28
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
